Compatibility of linezolid with commercial peritoneal dialysis solutions

Wolfgang Poeppl, Elena Rainer-Harbach, Manuel Kussmann, Petra Pichler, Markus Zeitlinger, Martin Wiesholzer, Heinz Burgmann, Gottfried Reznicek

Research output: Journal article (peer-reviewed)Journal article

4 Citations (Scopus)


PURPOSE: Results of a compatibility and stability study of linezolid admixed in commercial peritoneal dialysis (PD) solutions stored at various temperatures are reported.

METHODS: Test samples were prepared by adding linezolid i.v. injection (2 mg/mL) to infusion bags of 4 PD solutions (Extraneal, Nutrineal, Physioneal 40 Glucose 1.36%, and Physioneal 40 Glucose 2.27%, all from Baxter Healthcare Corporation). Assessments were conducted at various time points during storage of test samples at refrigeration temperature (6 °C) or room temperature (25 °C) for 14 days and at body temperature (37 °C) for 24 hours. Linezolid concentrations over time were determined by high-performance liquid chromatography, physical compatibility was determined by pH measurement and visual inspection, and antimicrobial activity was monitored by a disk diffusion method. The influence of solution warming by heating plate on drug stability was investigated.

RESULTS: Linezolid was stable in all tested solutions for 14 days at refrigeration and room temperatures and for 24 hours at body temperature. No linezolid adsorption to container material was detected. There were only minor variations in pH values, and visual inspection revealed no diluent abnormalities. With 1 exception, antimicrobial activity of >90% was retained in all PD solution samples for the duration of the study under all temperature conditions.

CONCLUSION: Linezolid injection 2 mg/mL remained stable and was compatible with the PD solutions studied for up to 2 weeks at refrigeration or room temperature and up to 24 hours at body temperature.

Original languageEnglish
Pages (from-to)1467-1477
Number of pages11
JournalAmerican Journal of Health-System Pharmacy
Issue number19
Publication statusPublished - 01 Oct 2018


  • Anti-Infective Agents/chemistry
  • Bacillus subtilis/drug effects
  • Chromatography, High Pressure Liquid
  • Dialysis Solutions/chemistry
  • Drug Incompatibility
  • Drug Stability
  • Drug Storage
  • Hydrogen-Ion Concentration
  • Linezolid/chemistry
  • Microbial Sensitivity Tests
  • Peritoneal Dialysis
  • Refrigeration


Dive into the research topics of 'Compatibility of linezolid with commercial peritoneal dialysis solutions'. Together they form a unique fingerprint.

Cite this